Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Post by juansitoon Nov 21, 2018 11:41am
60 Views
Post# 29004911

looks like 150K shares on the short side...

looks like 150K shares on the short side...they will need to cover before month ends...
maybe if someone jump in at 7,5 they will scare and squizz the shorter...
I dont know any more...
but i dosent look very good...now...
most of the time is invers to the look
when looks promising is going south, when looks depresing it can surprise...
(my hope only)
will see what november ends bring to Ico...
I really want to get out of underwater...
at least put it at 8 or 9...
how come they didnt secure financing for phase 2 yet?
my bet is that IF they annonce some kind of financing or jv or partnership will do a big jump in sp!
waiting and waiting for that...
who will sell at this level?
I see only defensive positions under 7,5
no agressive buyer in several days...

<< Previous
Bullboard Posts
Next >>